Literature DB >> 17651734

An active Src kinase-beta-actin association is linked to actin dynamics at the periphery of colon cancer cells.

Egle Avizienyte1, Melanie Keppler, Emma Sandilands, Valerie G Brunton, Steve J Winder, Tony Ng, Margaret C Frame.   

Abstract

Src controls the dynamic actin cytoskeleton in fibroblasts and in cancer cells, although it is not known how direct its effects are. Using FRET/FLIM imaging, we found that wild type Src associates directly, or indirectly, with peripheral beta-actin at integrin adhesions after serum stimulation, and that an active Src kinase domain is essential. Beta-actin can be directly tyrosine-phosphorylated by Src in vitro, and in a Src-dependent manner in cells. Moreover, beta-actin dynamics are suppressed when Src is rendered kinase-inactive. Surprisingly, debilitating mutations in the Src SH2 or SH3 domains do not suppress association of Src with beta-actin. This may therefore be an example of a spatially regulated Src kinase/substrate interaction that is controlling peripheral actin dynamics. Interestingly, there is no FRET between Src and beta-actin at cadherin-mediated cell-cell contacts, despite apparent co-localization there, demonstrating precise spatial specificity of Src/beta-actin complexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651734     DOI: 10.1016/j.yexcr.2007.04.037

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

Review 1.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

2.  Integrating receptor signal inputs that influence small Rho GTPase activation dynamics at the immunological synapse.

Authors:  Konstantina Makrogianneli; Leo M Carlin; Melanie D Keppler; Daniel R Matthews; Enyinnaya Ofo; Anthony Coolen; Simon M Ameer-Beg; Paul R Barber; Borivoj Vojnovic; Tony Ng
Journal:  Mol Cell Biol       Date:  2009-03-23       Impact factor: 4.272

Review 3.  Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis.

Authors:  Changxue Lu; Sheue-Yann Cheng
Journal:  Steroids       Date:  2011-04-05       Impact factor: 2.668

4.  Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.

Authors:  Changxue Lu; Li Zhao; Hao Ying; Mark C Willingham; Sheue-Yann Cheng
Journal:  Endocrinology       Date:  2010-02-04       Impact factor: 4.736

Review 5.  Multiphoton microscopy and fluorescence lifetime imaging microscopy (FLIM) to monitor metastasis and the tumor microenvironment.

Authors:  Paolo P Provenzano; Kevin W Eliceiri; Patricia J Keely
Journal:  Clin Exp Metastasis       Date:  2008-09-03       Impact factor: 5.150

6.  C-Src and c-Yes are two unlikely partners of spermatogenesis and their roles in blood-testis barrier dynamics.

Authors:  Xiang Xiao; Dolores D Mruk; Faith L Cheng; C Yan Cheng
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 7.  The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Authors:  Muireann T Kelleher; Gilbert Fruhwirth; Gargi Patel; Enyinnaya Ofo; Frederic Festy; Paul R Barber; Simon M Ameer-Beg; Borivoj Vojnovic; Cheryl Gillett; Anthony Coolen; György Kéri; Paul A Ellis; Tony Ng
Journal:  Target Oncol       Date:  2009-09-16       Impact factor: 4.493

8.  Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells.

Authors:  Muhammad Emaduddin; Mariola J Edelmann; Benedikt M Kessler; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2008-10-09       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.